Key result
High-dose long-term L-NAME administration produces an endothelium-independent decrease in vasoconstrictor activity, partly explained by a reduction in extracellular Ca2+ influx.
Why the study?
The study aimed to determine whether long-term high-dose l-NAME treatment affects vascular smooth muscle function independently of nitric oxide synthesis inhibition in rat thoracic aorta.
Does long-term l-NAME treatment impair smooth muscle function in rat thoracic aorta?
Does long-term l-NAME treatment impair smooth muscle function in rat thoracic aorta?
High-dose long-term l-NAME administration produces an endothelium-independent decrease in vasoconstrictor activity in rat thoracic aorta, partly due to reduced extracellular calcium influx.
Answers are grounded in this paper and cite their sources.
l-NAME may impair rat aortic smooth muscle independently of NO; leaves open relevance to in vivo hypertension or human therapy.
In this study, we aimed to elucidate whether the daily hypertensive dose of long-term N(G)-nitro-l-arginine methyl ester (l-NAME) treatment, could make a difference between endothelial and smooth muscle functions in rat thoracic aorta. We test the hypothesis that high-dose, long-term l-NAME treatment has a depressive effect on vascular smooth muscle contractile activity which is not related with nitric oxide (NO) synthesis inhibition. After 14 days of treatment, isometric tension and (45)Ca(2+) influx were measured in aortic tissues isolated from l-NAME(10) and l-NAME(100) hypertensive (10 and 100 mg/kg/day, systolic blood pressures 167 +/- 7 and 172 +/- 10 mmHg, respectively) and control normotensive rats (132 +/- 7 mmHg). In l-NAME(10)- and l-NAME(100)-treated rats, acetylcholine-induced relaxation in aortic rings was suppressed with no significant difference between the treatments. l-NAME(100) (but not l-NAME(10)) treatment, significantly inhibited contractile responses to phenylephrine, angiotensin II, and K(+) (80 mm) in endothelium-intact tissues. The effect of l-NAME(100) on phenylephrine-induced contractile responses was not observed after 3 days of treatment. In endothelium-denuded aortic tissues of l-NAME(100) (but not l-NAME(10))-treated rats, phenylephrine (1 x 10(-6) m)- and K(+) (80 mm)-induced contractions and (45)Ca(2+) influxes were significantly reduced. In Ca(2+)-free medium (0.1 mm EDTA), on the contrary, the transient contractions obtained by either phenylephrine (1 x 10(-6) m) or caffeine (1 x 10(-2) m), or the sustained contractions induced by 12-o-tetradecanoylphorbol-13-acetate (1 x 10(-6) m; a protein kinase C activator) in endothelium-denuded aortic rings, were not modified by both l-NAME treatments. These results indicate that in aortic rings from l-NAME hypertensive rats, low and high doses, long-term l-NAME administration may be associated with equivalent inhibition in NO-dependent vasodilator tone (corresponding to equivalent hypertension values); whereas only high-dose, long-term l-NAME administration produces an endothelium-independent decrease in vasocontrictor activity, at least partly explained by a reduction in extracellular Ca(2+) influx.
No takes yet. Share an insight, caveat, or question.
López et al. (2004) studied Hypertension. N(G)-nitro-l-arginine methyl ester (l-NAME) vs. Control normotensive rats was evaluated on Isometric tension and (45)Ca(2+) influx in aortic tissues. High-dose long-term L-NAME administration produces an endothelium-independent decrease in vasoconstrictor activity, partly explained by a reduction in extracellular Ca2+ influx.
Synapse has enriched 10 related papers. Consider them for comparative context: